A Hollings researcher is working on an idea to help oral oncologists better predict which patients are likely to develop cancer.

What doctors can do for aggressive form of prostate cancer Joe Biden is facing, and the impact the former president’s condition may have on others.

Two Hollings Cancer Center researchers are studying new ways to bring depression treatment to cancer survivors.

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.

Two women found friendship and solidarity as they go about their lives after a glioblastoma diagnosis.

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

As home to the state's only neuro-oncologists, MUSC Hollings Cancer Center can offer the latest care options and clinical trials to people with brain tumors.

The Engevik sisters live for science – and they get to do it together at MUSC.

Dr. Jennifer Dahne's focus on making behavioral health interventions accessible to more people has been recognized with a governor's award.

LOWVELO funds are enabling Leonardo Ferreira, Ph.D., to pursue his ideas to bring cellular therapy to solid tumors for cancer treatment.